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Abstract
Background: There are 11 variants of linker histone H1 in mammalian cells. Beyond their shared abilities to
stabilize and condense chromatin, the H1 variants have been found to have non-redundant functions, the
mechanisms of which are not fully understood. Like core histones, there are both replication-dependent and
replication-independent linker histone variants. The histone chaperones and other factors that regulate linker
histone dynamics in the cell are largely unknown. In particular, it is not known whether replication-dependent
and replication-independent linker histones interact with distinct or common sets of proteins. To better understand linker
histone dynamics and assembly, we used chromatography and mass spectrometry approaches to identify proteins that
are associated with replication-dependent and replication-independent H1 variants. We then used a variety of in vivo
analyses to validate the functional relevance of identified interactions.
Results: We identified proteins that bind to all linker histone variants and proteins that are specific for only one class of
variant. The factors identified include histone chaperones, transcriptional regulators, RNA binding proteins and ribosomal
proteins. The nuclear pore complex protein Tpr, which was found to associate with only replication-dependent linker
histones, specifically promoted their stability.
Conclusion: Replication-dependent and replication-independent linker histone variants can interact with both common
and distinct sets of proteins. Some of these factors are likely to function as histone chaperones while others may suggest
novel links between linker histones and RNA metabolism. The nuclear pore complex protein Tpr specifically interacts with
histone H1.1 and H1.2 but not H1x and can regulate the stability of these replication-dependent linker histones.
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Background
The basic repeating structural unit of eukaryotic chroma-
tin is the nucleosome core particle (NCP), which is a
structured package of 147 bps of DNA and a histone octa-
mer consisting of 2 copies of each core histone: H2A,
H2B, H3, and H4. There are also linker histones, H1,
flanking NCPs and sealing the structure with about 20 bps
of additional DNA. The involvement of H1 is crucial for
the formation and stabilization of chromatin structures
and for the regulation of gene expression [1, 2].
There are 11 variants of linker histone H1 in mamma-
lian cells: somatic replication-dependent variants (H1.1 to
H1.5), somatic replication-independent variants (H1.0,
H1x), and germ cell specific variants (H1t, H1T2m and
HILS1 for testicular cells, and H1oo for oocytes) [3]. The
replication-dependent variants are typically expressed
during S phase and are incorporated during into chromatin
during DNA replication, while the replication-independent
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variants are expressed throughout the cell cycle and can be
incorporated into chromatin outside of S phase. The
sequences of these H1 variants vary greatly in their
C-terminal domains. The individual functions of H1
variants are not fully understood. It was believed that H1
served as a global gene regulator by binding to chromatin
non-specifically. However, although partially redundant in
function, there is evidence indicating H1 variants have
distinct roles in gene regulation and development. While
deleting a single H1 variant did not lead to any observable
phenotype, the H1.2/H1.3/H1.4 triple knockout mouse
exhibited developmental defects and embryonic lethality
[4]. Microarray experiments showed that knockdown of
each H1 variant altered a different subset of genes [5]. The
expression levels and activities of the H1 variants were
also found to be highly regulated during cell differen-
tiation and tumorigenesis [6]. These observations suggest
the hypothesis that each H1 variant has its individual
function in the cells in addition to their roles as global
chromatin modifiers.
Studies on core histones indicate that replication-
dependent and replication-independent histone variants
can be involved in distinct protein complexes and
assembly pathways. For example, histone H3.1 is assem-
bled into chromatin in coordination with DNA replication
during S phage, while another variant, H3.3, is exchanged
throughout the cell cycle. The dynamics of H3.1 and H3.3
are mediated by distinct protein complexes that contain
different chaperones for each of the H3 variants. While
H3.1 and H3.3 complexes have some shared histone asso-
ciated proteins, such as NASP, ASF1A, ASF1B, HAT1,
and importin 4, there are also exclusive histone binding
partners in each complex. All three subunits of histone
chaperone CAF-1 are only found in the H3.1 complex,
while another histone chaperone, HIRA, is only found in
the H3.3 complex [7, 8]. CAF-1 and HIRA then dictate the
replication-coupled and replication-independent as-
sembly of these H3 variants.
Currently it is not known whether the dynamics of
replication-dependent and -independent variants of H1
are also regulated by distinct chaperones in a manner
similar to H3.1 and H3.3 complexes. Previous studies
proposed several linker histone chaperone candidates:
Nucleosome Assembly Protein 1(NAP1) [9], Nuclear
Autoantigenic Sperm Protein (NASP) [10], Nucleophos-
min (NPM1) [11], Prothymosin α (ProTα) [12], and
Template Activating Factor-I (TAF-1, also known as
protein SET) [13]. The roles of these interactions
between histone H1 and linker histone chaperones in
H1 storage, transport, chromatin assembly and disassem-
bly are not fully understood. How the linker histone cha-
perones interact with each H1 variant also remains to be
determined. To better understand H1 variant - protein in-
teractions, we purified non-chromatin associated protein
complexes containing 6 ×His-tagged H1 variants expressed
in Tetracycline-inducible U2OS cell lines using column
chromatography. Proteins associated with each H1 variant
were identified by mass spectrometry analysis. We found
replication-dependent and replication-independent H1
variants had distinct binding partners. For example, one
protein bound to replication-dependent H1.1 and H1.2,
nucleoprotein Tpr, was not found in the protein complex
containing replication-independent H1x. Tpr knockdown
leads to decreased levels of H1.1 and H1.2, but does not
affect H1x levels. These findings suggest that association
with variant-specific binding partners may regulate linker
histone dynamics.
Results
Generation of inducible U2OS cell lines expressing 6 ×
His-tagged H1 variants
To purify H1 variants and their associated proteins for
identification, we generated tetracycline-inducible U2OS
cell lines over-expressing 6 × His-tagged H1 variants
H1.1, H1.2 or H1x by transfecting U2OS cells engineered
for tetracycline-inducible expression with pT-Rex-
DEST31 plasmids carrying the corresponding H1 variant
sequences (Fig. 1a). Cellular fractionation revealed that
the vast majority of 6 ×His-tagged linker histones were
in the nuclear fraction (Fig. 1b), indicating the exogenous
H1 proteins were properly localized. Since histone pro-
teins are highly basic, excess accumulation of histones
could disrupt normal chromatin structures and cause
cytotoxicity. To verify that our over-expression of H1
variants did not disrupt normal cell functions, we isolated
total histones from uninduced and doxycycline-induced
U2OS cells. Figure 1c shows a Coomassie stained gel of
uninduced and induced cells expressing histone H1.1,
H1.2 and H1x. It is clear that H1 induction does not result
in an overall increase in linker histone abundance. MNase
digestion assays further confirmed that over-expression of
6 ×His-tagged H1 variants did not significantly alter
nucleosome organization or repeat length (compare time
points from uninduced samples to the Dox-induced
samples in Fig. 1d–f ). Thus we conclude that these cell
lines are suitable as the source for H1-containing protein
complex purification.
Purification and identification of H1 complexes
To analyze proteins associating with the soluble pool of
the H1 variants, we purified H1.1, H1.2 and H1x from
U2OS whole cell extracts by sequential chromatography
with an anion exchange column (Mono Q) and an affi-
nity column (nickel column). The specific order of the
chromatography was used to optimize the concentration
of proteins prior to mass spec analysis. Interestingly,
H1.1 eluted in two separate peaks on the Mono Q column,
while H1.2 and H1x both eluted in only one peak
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(Fig. 2a–c). Each peak eluting from the Mono Q column
was collected and pooled separately, and chromato-
graphed on a nickel chelate column (Fig. 2d–f, data not
shown for the second peak of H1.1). We performed mock
purification from whole cell extracts of untransfected
U2OS Tet/On cells, which did not express 6 ×His-tagged
proteins, to serve as negative controls. For the mock puri-
fications, extracts were resolved on a Mono Q column
and the fractions containing an equivalent salt concentra-
tion as the peak of the H1-containing fractions was then
resolved on a nickel chelating column.
Peak samples eluting from the nickel chelate column
containing each histone variant, as well as the comparable
negative control fraction, were analyzed in duplicate by
mass spectrometry. A complete list of the proteins identi-
fied, as well as the number of unique peptides observed in
Fig. 1 Over-expression of 6 × His-tagged H1 Variants Does Not Alter Global Chromatin Structure. a U2OS Tet/On cells were transfected with
plasmids encoding 6 × His-tagged human histone H1 variants. These cells were incubated 72 h with or without doxycycline before extracted.
Whole cell extracts were resolved by SDS-PAGE gel, and immunoblotted with anti-His antibodies. b Untransfected (UN) U2OS Tet/On cells or
U2OS Tet/On cells expressing H1 variants (H1.1, H1.2 and H1x) were incubated with doxycycline for 72 h. Whole cell, cytosolic and nuclear extracts
of these cells were resolved by SDS-PAGE gels and visualized by western blotting with antibodies targeting proteins indicated on the right. c Total
histones were extracted from untransfected (UN) U2OS Tet/On cells or Doxycycline-induced U2OS cells expressing 6 × His-tagged H1 variants
(H1.1, H1.2 and H1x) using acid precipitation method. 30 μg of each sample was resolved by SDS-PAGE gel, and visualized by coomassie staining
or immunoblotting with anti-His antibodies. d–f Nuclei from uninduced (UN) or Doxycycline induced (Dox) U2OS cells transfected with vectors
expressing H1.1 (d) , H1.2 (e) or H1x (f) were digested with 0.2 U/ml (Sigma units) of MNase at 37 °C for various lengths of time, then quenched with
EDTA. Digested DNA samples were purified using phenol extraction and ethanol precipitation, and resolved on 1 % agarose gel with EtBr staining
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each analysis, is listed in Additional file 1: Table S1. The
distribution of specificities of the identified linker histone
binding proteins for H1.1, H1.2 and H1x is represented by
a Venn diagram in Fig. 3a. Approximately half of the pro-
teins identified interact with more than one linker histone
variant while half are specific for a single H1 species.
The protein list contains a large number of ribosomal
proteins. Several recent proteomic studies have also found
that linker histones bind to ribosomes and this interaction
has been implicated in transcriptional repression [14–17].
Recent proteomic studies of linker histone binding proteins
have used a fundamentally different approach where a
Fig. 2 Purification of H1.1, H1.2 and H1x Complexes. a–c Soluble whole cell extracts of U2OS cells expressing 6 × His - tagged H1.1 (a), H1.2 (b)
or H1x (c) were purified on a Mono Q column. Top panel: 1 ml fractions were collected, resolved by SDS-PAGE gel, and immunoblotted with
anti-His antibodies. Bottom panel: chromatogram showing chromatography conditions used. d–f Peaks containing 6 × His – tagged H1.1 (d),
H1.2 (e) or H1x (f) from Mono Q column were pooled and applied to a nickel column in loading buffer containing 20 mM imidazole, washed
with 50 mM imidazole and then eluted with 500 mM imidazole. Top panel: 1 ml fractions were collected, resolved by SDS-PAGE gel,
and visualized by immunoblotting with anti-His antibodies. Bottom panel: chromatogram showing chromatography conditions used
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histone H1 variant was immobilized and incubated with
nuclear or nucleolar extracts [14, 15]. In addition to these
differences in experimental approach, these studies used a
different linker histone variant than those used in the
current study. Despite these differences, there is significant
overlap in the H1 interacting proteins identified. As seen in
Fig. 3b, there is approximately 30 % overlap in the linker
histone binding proteins identified in the current study and
in the previous studies. In addition, if only the linker
histone binding proteins identified from the same cell
line are considered (U2OS), the current study identi-
fied more than half of the linker histone binding pro-
teins found by Kalashnikova and colleagues (Fig. 3c).
Table 1 lists all of the non-ribosomal proteins found
to co-purify with the linker histones that were detected
by at least 5 peptides in both of the duplicate samples
(average number of peptides listed). These proteins are
divided into 6 groups based on their pattern of interaction.
Group 1 consists of the proteins that co-purified with all
three linker histones. Group 2 proteins co-purified with
the replication-dependent H1.1 and H1.2 but not with the
replication-independent H1x. Group 3, group 4 and group
5 proteins were specifically associated with a single
histone H1 variant (H1.1, H1.2 and H1x, respectively)
and, as expected, each of these groups contained the
corresponding H1 variant (proteins specifically identified
in H1.1 peak 2 are indicated by an asterisk). Group 6
proteins were associated with both histone H1.1 and H1x.
The group 1 proteins included two proteins that had
previously been identified as histone chaperones, nucleolin
Fig. 3 Graphical representation of identified linker histone binding proteins. a Venn diagram of the distribution of proteins co-purifying with
histones H1.1, H1.2 and H1x (as indicated). b Venn diagram of the distribution of linker histones binding proteins identified in the current study
(H1.1, H1.2, H1x and the studies of Kalashnikova et al. 2013 and Szerlong et al. 2015 (as indicated) [14, 15]. c Venn diagram of the overlap of liner
histone binding proteins identified from U2OS cells in the current study and the study of Kalashnikove et al. 2013 (as indicated) [15]
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and nucleophosmin (NPM1) [18]. Nucleolin and nucleo-
phosmin are broad specificity histone binding proteins and
have been found to associate with both core and linker
histones [11, 19–22]. Group 1 also included the SSRP
subunit of the FACT complex, which also has been shown
to interact with both core and linker histones [15, 23].
The second subunit of FACT, Spt16, was identified as
specifically interacting with histone H1.1. However,
this classification was due to a high level of Spt16
peptides in the negative control sample. Therefore, it
is likely that both subunits of FACT are bound to all
three of the linker histone variants tested.
Group 1 also included SRP68 and SRP72. Components
of the signal recognition particle, SRP68 and SRP72 have
also been shown to form a heterodimeric complex
distinct from the signal recognition particle. In addition to
its role in translation, the SRP68/72 complex was also
found to bind histone H4 molecules that contain arginine
3 methylation [24].
YBX1 and YBX3 also co-purified with all three linker
histones. Y box-binding proteins bind to Y box consen-
sus promoter elements and are involved in mRNA pro-
cessing [25]. YBX1 was found to be recruited together
with PURα and histone H1.2 to the p53 target gene Bax
Table 1 Linker histone binding proteins
Table lists the selected proteins identified by mass spectrometry associated with the linker histones H1.1, H1.2 and H1.X (color coded as indicated). Table lists
the average number of peptides identified from each linker histone purification. The averages are derived from 2 to 4 replicates. * denotes proteins identified
in histone H1.1 Mono-Q peak 2. = ALL H1’s (GROUP 1), = H1.1 AND H1.2 (GROUP 2), = H1.1 (GROUP 3), = H1.2 (GROUP 4),
= H1.X (GROUP 5), = H1.1 AND H1.X (GROUP 6)
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in order to repress p53-induced transcription [26]. Our
data indicates that YBX1 not only associates with H1
variant H1.2, but with H1.1 and H1x as well. Interes-
tingly, these Y box proteins were only detected in the
H1.1 complex that corresponded to the second peak of
H1.1 on the Mono Q column.
Five of the group 1 proteins are linked to N6-methylade-
nosine modification of mRNA. VIR (virilizer homolog),
WTAP (Wilms Tumor Associated Protein), ZC3H13 and
Hakai are all components of the WTAP complex that
serves to target the METTL3 and METTL14 methyltrans-
ferases to their substrate [27–30]. In addition, YTDC1 is a
YTH domain protein that can function as a reader of N6-
methyladenosine [31–34].
The remaining group 1 proteins include a cyclin/cdk
complex; CCNL1 and CDK11b. Linker histones are
highly phosphorylated and often used as non-specific
substrates in kinase assays. In fact, CDK11b has been
shown to be able to phosphorylate histone H1 in vitro
[35]. The observation that the CCNL1/CDK11b complex
can be purified in association with linker histones sug-
gests that H1s may be a specific substrate of this kinase
complex. Finally, all three H1 variants associate with the
ubiquitin hydrolase UBP34.
The group 2 proteins bind specifically to the replication-
dependent H1 variants H1.1 and H1.2 but don’t form a
complex with the replication-independent variant H1x. The
group 2 proteins include 4 subunits of the PAF1 complex,
PAF1, CTR9, CDC73 and LEO1 [36]. The specificity of the
interaction between the PAF1 complex and H1.1 and H1.2
is consistent with a recent study that showed that PAF1
co-purified with epitope tagged H1.1 and H1.2 but not
with the other replication-dependent H1 variants H1.3,
H1.4, H1.5 or with the replication-independent variant
H1.0. The association of the PAF1 complex with H1.1 and
H1.2 was shown to function with Cul4A in transcription-
associated ubiquitylation [37].
CHD8 has previously been shown to function in tran-
scriptional repression of p53 and β-catenin target genes
through the recruitment of histone H1 [38, 39]. The prote-
omic data presented here suggests that the interaction
between CHD8 and linker histones is variant specific.
The nuclear pore complex protein Tpr was also found to
be replication-coupled H1 variant specific. Tpr (translo-
cated promoter region) is a component of the nuclear pore
complex (NPC), forming fibrous structures that extend into
the nuclear interior [40]. Tpr is required for establishing
heterochromatin exclusion zones in the vicinity of NPCs
[41]. In addition to its roles in NPC architecture, Tpr is also
involved in mRNA, unspliced RNA and nuclear protein ex-
port [42–44]. Depletion of Tpr induces nuclear accumula-
tion of p53, and facilitates autophagy [45].
Proteins that specifically co-purified with histone H1.1
(group 3) included several known histone chaperones.
NapP1L1 and SET were recently shown to bind histone
H1.0 in vitro [16, 46]. NAP1L4 has not previously been
demonstrated to interact with linker histones.
Group 3 contained several proteins involved in RNA
metabolism. These included three poly A binding pro-
teins, PABP1, PABP3 and PABP4, as well as the RNaseP
subunit POP1 [47, 48]. In addition, proteins involved in
transcriptional regulation, NDE1, UBF1 and S30BP were
also found to be specific for histone H1.1.
H1.2 specific binding partners (group 4) included
DNA damage-binding protein 1 (DDB1) and protein
VPRBP (also known as DDB1-CUL4-associated factor 1,
DCAF1). DDB1 and VPRBP are both members of an E3
ubiquitin-protein ligase complex, named CUL4A-RBX1-
DDB1-DCAF1/VPRBP complex, which is responsible for
methylation-dependent ubiquitylation [49]. VPRBP and
DDB1 were recently shown to co-purify with both H1.1
and H1.2 along with Cul4A and the PAF1 complex [37].
The distinct properties of the PAF1 and Cul4A complex
subunits in the U2OS cells suggest that the specificity of
the interaction between the Cul4A complex and linker
histones is subject to cell type specific regulation.
Group 4 contained two RNA helicases, DDX21 and
DDX50 and the nucleolar RNA binding protein EBP2.
Group 4 also contained the transcriptional regulators
TAF5 and TIF1B, as well as CHD7. While CHD7 has
not been shown to be associated with linker histones,
these results suggest that it may function in a manner
analogous to CHD8.
Only two proteins were found to be exclusive binding
partners of H1x (group 6). These were ubiquitin carboxyl-
terminal hydrolase 15 (USP15) and insulin-like growth
factor 2 mRNA-binding protein 3 (IGF2BP3). USP15 is a
deubiquitinating enzyme that can bind to ubiquitinated
H2A/H2B dimers, and removes ubiquitin from ubiquiti-
nated H2B that are not in nucleosomes [50]. IGFBP3 be-
longs to a family of three IGF-II mRNA-binding proteins
that can bind to the 5′ UTR of the insulin-like growth fac-
tor II leader 3 mRNA and regulate the translation of
insulin-like growth factor II during late mammalian devel-
opment [51]. Interactions between USP15 and IGFBP3
and linker histones have not been reported previously.
Group 6 is an eclectic collection of proteins that co-
purified with both H1.1 and H1x. This group includes the
RNA binding proteins SRSF3 and SRSF7, the zinc finger
protein ZNF16 and the anti-microbial protein dermcidin.
Interactions between nucleoprotein Tpr and H1 variants
The proteomics data clearly demonstrate that linker
histones participate in a complex set of interactions that
display varying degrees of specificity for the H1 variants.
To explore in more detail the distinction between
replication-dependent (H1.1 and H1.2) and replication-
independent (H1x) H1 variants, we examined whether
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the specificity observed for replication-dependent H1.1
and H1.2 displayed by Tpr was a reflection of a specific
in vivo connection between Tpr and replication-
dependent linker histones. Unlike the PAF-1 complex
and CHD8, which were also identified in the H1.1 and
H1.2 complexes but not in the H1x complex (Table 1),
Tpr has not been previously shown to interact with
linker histones. To confirm the potential for interactions
between Tpr and H1 variants in vivo, we resolved
soluble whole cell extracts of U2OS cells expressing
H1.1, H1.2 or H1x by size exclusion chromatography
(Fig. 4). In all three cases, the peaks of H1 variants over-
lapped with the Tpr peak in a very high molecular weight
complex (Fraction 9–10 in Fig. 4a, Fraction 9 in Fig. 4b,
and Fraction 8–10 in Fig. 4c). These large complexes are
likely due to other proteins associated with Tpr and/or H1
variants through direct or indirect interactions. The
overlapping elution profiles of the linker histones and Tpr
is consistent with the possibility that Tpr can form com-
plexes with the linker histones in vivo but does not pro-
vide biochemical evidence for specific association of Tpr
with the replication-dependent linker histones. Recprical
co-immunopreciptations were also attempted to obtain
additional evidence for for the specific interactions
between Tpr and linker histones. However, currently avail-
able anti-Tpr antibodies were efficient for the immunopre-
ciptation of Tpr and its associated proteins.
Tpr knockdown specifically reduces replication-
dependent H1 variant levels via protein degradation
To determine whether the observed interactions between
Tpr and replication-dependent linker histones are func-
tionally relevant, we treated U2OS cells expressing 6 ×
His-tagged H1.1, H1.2 or H1x with Tpr-targeting siRNA
Fig. 4 Tpr Co-Elutes with H1 Variants on Size Exclusion Column. Soluble whole cell extracts of U2OS cells expressing 6 × His - tagged
H1.1 (a), H1.2 (b) or H1x (c) were resolved by gel filtration chromatography (Superose 6). Fractions (indicated by numbers at top of gels)
were precipitated with 20 %w/v TCA, then resolved by SDS-PAGE gel, and visualized by immunoblotting with anti-Tpr or anti-His antibodies
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in order to knockdown the expression of Tpr proteins.
Surprisingly, we found that siTpr treated cells, which had
significantly reduced Tpr immunofluorescence signals,
also showed reduced immunofluorescence signals of 6 ×
His-tagged replication-dependent variants H1.1 and H1.2,
but not replication-independent variant H1x (Fig. 5a). In
both control siRNA and Tpr siRNA treated cells, all three
H1 variants were localized within the nucleus, indicating
that the loss of Tpr did not disrupt the nuclear distribu-
tion of histone H1. The fluorescence intensities of the
signals for Tpr and the H1 variants, relative to the signal
for DAPI, were quantitated and plotted (Fig. 5b). Based on
a linear regression analysis of the data there was a clear
positive correlation between the level of Tpr and the levels
of histone H1.1 and H1.2 (r = 0.83 and 0.89, respectively)
while there was no correlation between the level of Tpr
and the level of H1x (r = 0.17). Consistent with the
immunofluorescence data, we also observed reduced H1.1
and H1.2 protein levels in Tpr siRNA treated cells on
western blots; however H1x protein levels were not
affected (Fig. 5c).
The reduction in H1.1 and H1.2 levels in Tpr knock-
down cells could have been a result of a decrease in
mRNA abundance or by protein destabilization. In order
to investigate the effect of Tpr depletion on histone H1
gene expression, we performed quantitative real-time
PCR analysis on the mRNA levels of H1.1, H1.2, and
H1x in U2OS cells treated with either control siRNA or
Tpr siRNA. Tpr knockdown did not cause any signi-
ficant decrease in the mRNA levels of any of the three
H1 variants (Fig. 6a and b).
To test whether Tpr is required for histone H1.1 and
H1.2 protein stability, we treated U2OS cells with
MG132, which is a cell permeable proteasome inhibitor.
Fig. 5 Tpr Knockdown Specifically Reduces Replication-dependent H1 Variant H1.1 and H1.2 Levels. a Untransfected (UN) U2OS Tet/On cells or
U2OS Tet/On cells expressing H1 variants (H1.1, H1.2 and H1x) were treated with either control siRNA or siRNA targeting protein Tpr for 72 h.
The cells were simultaneously stained with DAPI (blue), anti-Tpr (Red), and anti-His (Green). Overlay of anti-Tpr and anti-His staining was shown for
comparison. b Scatter plot of quantified fluorescence intensities from Fig. 5a. Quantification and regression analysis was performed as described
in Experimental Procedures. c Untransfected (UN) U2OS Tet/On cells or U2OS Tet/On cells expressing H1 variants (H1.1, H1.2 or H1x) were treated
with either control siRNA or siRNA targeting protein Tpr for 72 h. 20 μg whole cell extracts of each sample were resolved on SDS-PAGE gel, and
visualized by immunoblotting with antibodies targeting proteins indicated on the right
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In the presence of MG132, H1.1 and H1.2 protein levels
were restored in Tpr siRNA treated cells to levels com-
parable to those of control siRNA treated cells (Fig. 6c).
Immunofluorescence microscopy of MG132 treated cells
also confirmed this rescue of H1.1 and H1.2 protein
levels (Fig. 6d). Quantitation of the immunofluorescence
data indicated a clear decrease in the correlation of the
levels of Tpr and histones H1.1 and H1.2 with an
increase in the number of cells with a low level of Tpr
that maintain a high level of the replication-dependent
linker histones (Fig. 6e). It is important to note that in
MG132 treated cells all H1 variants were still localized
within the nucleus, indicating that loss of Tpr did not
cause replication-dependent H1 proteins to accumulate
in the cytosol suggesting that Tpr is not required for the
nuclear import of replication-dependent linker histones.
These results suggest that the specific interaction between
Tpr and replication-dependent histone H1 variants
detected biochemically is a reflection of a specific in vivo
interaction. Further, the interaction between Tpr and
histones H1.1 and H1.2 is critical to maintain the proper
abundance of these linker histones.
Discussion
There is accumulated evidence indicating functional
differentiation among linker histone variants. The abun-
dance of H1 variants fluctuates in diverse cell types and
at development stages [6, 52]. Their ability to condense
chromatin also varies (reviewed in [53]). In addition, the
H1 variants can engage in a wide range of different protein-
protein interactions (reviewed in [16, 54]). Several previous
proteomic studies focused on the characterization of
the linker histone variants H1.0 and H1.2 interaction
networks, however the comparison of replication-
dependent and replication-independent H1 variants is
still lacking [14, 15, 37]. In order to understand how
replication-dependent and replication-independent H1
variants carry out differentiated functions through
protein-protein interactions, we purified protein complexes
containing 6 ×His-tagged replication-dependent H1 vari-
ants H1.1 and H1.2, or replication-independent variant
H1x, and identified their binding partners using mass spec-
trometric analysis.
Broadly speaking, our proteomic characterization of
linker histones binding proteins identifies four groups of
proteins that interact with linker histones. We used sol-
uble whole cell extracts as the starting material for the H1
purifications to facilitate the identification of histone
chaperones that would regulate the transport and assem-
bly of the linker histones. Indeed, a significant fraction of
the H1 interacting proteins are previously known histone-
binding proteins. While many of these proteins have pri-
marily been characterized in the context their functions as
core histone chaperones, it will be interesting to deter-
mine how they also impact linker histone dynamics.
The well-characterized function of linker histones in
the regulation of transcription is reflected in the abun-
dance of transcription factors identified as linker histone
binding proteins. The observation that some transcrip-
tion factors are highly specific for a single histone H1
variant suggests that some of the unique functions of
the linker histones may be mediated by protein-protein
interactions that regulate specific subsets of genes.
The other two groups of proteins were related to RNA
biology. The largest groups of interacting factors were
ribosomal proteins. The interaction of linker histones
with ribosomes has been observed both in vitro and in
vivo and has been implicated in transcriptional repres-
sion [14, 15, 17]. We also identified a number of pro-
teins involved in RNA metabolism including RNA
binding proteins and RNA helicases. Surprisingly, mul-
tiple members of the WTAP complex, which is required
for a significant fraction of the N6-methyladenosine
modification in the cell, as well as the N6-methyladeno-
sine reader protein YTDC1 were associated with all
three H1 variants [28]. Together, these results suggest
the intriguing possibility that linker histones may pro-
vide an important link between chromatin structure and
RNA metabolism.
Surprisingly, NASP (nuclear antigenic sperm protein)
was not found to associate with any of the histone H1
variants in the present study and has not been identified
in the recent proteomic analyses of in vivo linker histone
complexes [16, 26, 37]. NASP was one of the first pro-
teins proposed to be a linker histone chaperone and, in
fact, can bind linker histones with nM affinity in vitro
[55–57]. The inability to identify NASP as linker
histone-associated protein in multiple studies suggests a
number of possibilities. NASP may not interact with
linker histones to a significant extent despite the demon-
strated in vitro affinity. Alternatively, NASP may interact
in vivo with only a subset of the linker histone variants
that have not yet been examined by proteomic methods.
In comparing the proteins that co-purified with each
of the H1 variants, we found that the three H1 variants
had shared binding partners that were identified in earl-
ier studies, such as nucleophosmin, nucleolin and FACT
complex subunits SPT16 and SSRP1, nucleolin, nucleo-
phosmin (NPM1) and Y box-binding proteins YB1, YB2
and YB3. These H1-associating proteins may contribute
to the common functions of H1 variants. Importantly,
we identified shared components found in the replication-
dependent H1 variant complexes that were not associated
replication-independent H1 variants. These factors in-
clude the PAF1 complex, CHD8 and nucleoprotein Tpr.
The recent study from Kim and colleagues demonstrated
that the PAF1 complex is not associated with histone
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Fig. 6 (See legend on next page.)
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H1.0 consistent with the specificity of this complex
for replication-dependent linker histones [37]. These
exclusive protein-protein interactions may be crucial for
mediating cell cycle-dependent functions of H1 variants.
The interactions of the PAF-1 complex and CHD8
with linker histones have demonstrated functions in
transcriptional regulation [37–39]. However, a link be-
tween Tpr and linker histones has not previously been
identified. Our analysis of Tpr siRNA knockdown cells
supports the proteomic data that indicated that Tpr
engages in specific interactions as Tpr knockdown re-
duced the levels of replication-dependent H1 variants
H1.1 and H1.2, but not replication-dependent H1 variant
H1x. Future studies will determine whether Tpr also inter-
acts with the remaining replication-dependent linker
histones, H1.3, H1.4 and H1.5 or, whether, like the PAF1
complex, it is specific for H1.1 and H1.2.
While Tpr is required for the stability of histones H1.1
and H1.2, the functional significance of their interaction
is not clear. As Tpr is a component of the nuclear pore
complex, the most straightforward model is that Tpr is
specifically involved in the nuclear import of replication-
dependent linker histones. This model predicts that if
the levels of H1.1 and H1.2 were restored in cells lacking
Tpr that the histones would accumulate in the cyto-
plasm. However, when the Tpr siRNA knockdown was
performed in the presence of the proteasome inhibitor
MG132, we observed no cytoplasmic accumulation of
H1.1 and H1.2.
A second possibility is that Tpr can function as a
histone chaperone that participates in the targeting of
replication-dependent linker histones to sites of chroma-
tin assembly. Indeed, Tpr contains a region nears the
COOH-terminus that is highly enriched in aspartic acid
and glutamic acid as is observed in many histone chape-
rones. In addition, a recent proteomic analysis of nascent
chromatin structure identified Tpr as a chromatin-
associated protein [58].
Another potential function for the interaction of Tpr with
histones H1.1 and H1.2 may be related to involvement of
Tpr in the formation of heterochromatin exclusion zones
(HEZs) around nuclear pores. While heterochromatin
localizes near the nuclear envelope, regions near the
nuclear pores are devoid of heterochromatin through the
formation of Tpr-dependent HEZs [41]. The interaction
between Tpr and replication-dependent H1 variants may
be important for the maintenance of HEZs. Tpr may
stabilize and preserve H1 variants with minimal DNA
compaction abilities, such as H1.1 and H1.2, which esta-
blishes a basal level of chromatin packaging around HEZs,
while keeping out H1 variants that promote strong con-
densation, such as H1x. To test this hypothesis, it would
be interesting to investigate the interactions between Tpr
and other H1 variants with higher affinity and/or higher
capacity for the compaction of nucleosomes, such as H1.3
and H1.4 (Reviewed in [53]).
Conclusions
We have isolated and analyzed the soluble forms of the
replication-dependent linker histones H1.1 and H1.2 and
the replication-independent linker histone H1x. These
linker histones interact with both a common group of
proteins and with variant-specific interacting proteins.
One protein that is specifically associated with H1.1 and
H1.2 is nuclear pore complex protein Tpr. Tpr was not
required for the nuclear import of histones H1.1 and
H1.2. However, knockdown of Tpr expression resulted
in a specific decrease in protein stability of the replication-
dependent linker histones.
Methods
Antibodies and other materials
Sources of antibody employed are as follows: anti-His.M8
from Thermo Fisher Scientific was used for western blots;
anti-His6 from Roche was used for immunofluorescence
microscopy; anti-Tpr from Abcam. Control siRNA
(sc-37007) and siRNA targeting Tpr (sc-45343) was
purchased from Santa Cruz Biotech.
(See figure on previous page.)
Fig. 6 Tpr Stabilizes Replication-dependent H1 Variant H1.1 and H1.2 by Preventing Protein Degradation. a–b mRNA levels of H1.1, H1.2 or H1x were
quantified by quantitative Real-Time PCR in untransfected U2OS Tet/On cells (a) or U2OS Tet/On cells expressing H1 variants H1.1, H1.2 or H1x (b)
treated with either control siRNA or siRNA targeting Tpr for 48 h. Expression levels of histone H1 genes were normalized relative to levels of GAPDH.
Each experiment was completed on three biological replicates where each biological replicate was obtained in triplicate, and the mean of these values
was used for further analysis. Statistical analysis was carried out using unpaired Student’s t-test: p≤ 0.05 (*), p≤ 0.01 (**), and p≤ 0.001 (***). The data
are presented as means ± standard deviations (n = 3). c Untransfected (UN) U2OS Tet/On cells or U2OS Tet/On cells expressing H1 variants (H1.1, H1.2
or H1x) were treated with either control siRNA or siRNA targeting protein Tpr for 72 h. For the last 3 h of siRNA transfection, 20 μM of MG132 was
added to the media. 20 μg whole cell extracts of each sample were resolved on SDS-PAGE gel, and visualized by immunoblotting with antibodies
targeting proteins indicated on the right. d Untransfected (UN) U2OS Tet/On cells or U2OS Tet/On cells expressing H1 variants (H1.1, H1.2 or H1x)
were treated with either control siRNA or siRNA targeting protein Tpr for 72 h. For the last 3 h of siRNA transfection, 20 μM of MG132
was added to the media. Treated cells were then simultaneously stained with DAPI (blue), Tpr (Red), and 6 × His-tag (Green). Overlay of
anti-Tpr and anti-His staining was shown for comparison. e Scatter plot of quantified fluorescence intensities from Fig. 6d. Quantification
and regression analysis was performed as described in Experimental Procedures
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Plasmid construction
The human Ultimate ORF of histone H1.1 (IOH35288),
H1.2 (IOH5275), and H1x (IOH3417) (Thermo Fisher
Scientific) were inserted into mammalian expression
vector pT-Rex-DEST31 (Thermo Fisher Scientific), which
adds a 6 ×His-tag at the NH2-terminus. The resulting
constructs were transferred into DH10B E. coli strain for
production.
Cell culture and transfections
Tetracycline-inducible human osteosarcoma cell line
U2OS (kind gift from Dr. Dan Schoenberg) was grown in
McCoy’s 5A media supplemented with 10 % (v/v) fetal
bovine serum, 50 U/ml penicillin, 50 mg/ml streptomycin,
and 1 % L-glutamate (Sigma) at 37 °C in 5 % CO2 supply.
The U2OS cells were transfected with pT-Rex-DEST31
plasmids carrying H1.1, H1.2 or H1x using X-tremeGENE
HP DNA transfection reagent (Roche) following the man-
ufacturer’s instruction. Transfected clones were selected
against 200 mg/ml G418 and 10 mg/ml blasticidin (Gibco,
Thermo Fisher Scientific). Stable clones were induced by
1 μg/ml doxycycline (Sigma) for 48 h. The expression of
6 ×His-tagged H1 variants was confirmed by western blot.
Cell fractionation
Cytosolic and nuclear extracts were prepared from
U2OS cells as previously described [59]. The resulting
extracts were resolved on SDS-PAGE gels and visualized
on western blots.
Histone extractions
Total histones were prepared from U2OS cells as previ-
ously described [60]. The resulting histone pellets were
resuspended in DN (300) buffer (300 mM NaCl, 25 mM
Tris pH 7.0, 0.1 mM EDTA, 10 % glycerol, and 0.5 mM
phenyl methyl sulfonate fluoride), and resolved on 18 %
SDS PAGE gels. Linker histones isolated from chicken
erythrocyte nuclei were also loaded in the gels as
controls [56].
Micrococcal nuclease digestion assays
1 × 107 U2OS cells were collected and washed with cold
PBS, and incubated in lysis buffer (300 mM HEPES
pH7.5, 60 mM KCl, 300 mM sucrose, 5 mM K2HPO4,
5 mM MgCl2, 2 mM EDTA, and 0.5 % Triton X-100) for
5 min on ice. The cells were then broken with 7 gentle
strokes in a type B Dounce homogenizer. Nuclei were
pelleted by centrifuging at 120 × g for 10 min. The
pelleted nuclei were washed with 1 ml MNase digestion
buffer (10 mM Tris pH7.5, 15 mM NaCl, 1 mM CaCl2,
60 mM KCl, and 0.2 mM phenyl methyl sulfonate fluo-
ride), resuspended in 1 ml MNase digestion buffer, and
digested with 0.2 U/ml (Sigma units) of MNase at 37 °C
for various lengths of time. Digestions were stopped with
10 mM EDTA followed by incubation with 0.1 mg/ml
proteinase K at 37 °C for 5 min. The resulting DNA
samples were isolated using phenol extraction and etha-
nol precipitation, and resolved on 1 % agarose gel [61].
Protein expression and purification
U2OS cells with 6 × His-tagged H1 inserts were induced
by 1 μg/ml doxycycline (Sigma). After 48 h, cells were
harvested, washed with PBS, and lysed with NP40 lysis
buffer (150 mM NaCl, 50 mM Tris pH7.5, 10 %
Glycerol, 0.75 % NP40) containing EDTA-free protease
inhibitor cocktail (Roche) and 0.5 mM phenyl methyl
sulfonate fluoride. The resulting whole cell extracts were
applied to a Mono Q 5/50 GL column (GE Healthcare
Life Sciences). Proteins were eluted with a NaCl gradient
from 50 mM to 500 mM in 15 column volumes, then
1 M for 5 column volumes. Fractions containing eluted
6 ×His-tagged H1 variants were pooled, desalted on
desalting columns (GE Healthcare Life Sciences), and then
applied to an HiTrap Chelating HP Column (1 ml, GE
Healthcare Life Sciences) charged with Ni2+. The column
was then washed extensively with NP40 lysis buffer con-
taining 50 mM imidazole. Bound proteins were eluted
with NP40 lysis buffer containing 500 mM imidazole.
Fractions were collected and resolved on western blots.
Mass spectrometry
Tryptic peptides were desalted online using a μ-precolumn
(PepMap100, C18, 5 μm, 100 Å, 0.3 x 50 mm, Thermo-
Fisher, Waltham, MA, USA) and separated based on hydro-
phobicity at a flow rate of 2 μL/min (C18Aq, 5 μm, 300 Å
0.2 × 150 mm, Michrom Bioresources Inc., Auburn, CA,
USA). Peptides were introduced into a ThermoFisher LTQ
Orbitrap XL mass spectrometer (ThermoFisher, Waltham,
MA, USA) with the aid of micro/nanospray ionization
source (Michrom Bioresources Inc., Auburn, CA, USA).
Mobile phase A (MPA) consisted of HPLC water with
0.1 % v/v formic acid (J.T. Baker, Center Valley, PA, USA)
and mobile phase B (MPB) consisted of ACN (EMD Milli-
pore, Billerica, MA, USA) with 0.1 % v/v formic acid. The
HPLC gradient was ramped from 2 to 40 % MPB from 5 to
155 min, followed by a high organic wash and column
equilibration period. The heated capillary temperature and
electrospray voltage were set to 175 °C and 2.0 kV. The top
5 molecular ions (2+/3+ charges) were selected for CID
fragmentation in a data-dependent fashion. Molecular ions
were analyzed in the Orbitrap (AGC:1000 K ions; 60 K
mass resolution; 300 ms max injection time, 1 microscan,
precursor scan enabled). Molecular ions were selected and
subjected to CID fragmentation in the linear ion trap
(NCE: 35 %, AGC: 10 K ions; 300 ms max injection time).
Dynamic exclusion parameters were enabled (30s ±
25 ppm, repeat count:1). Protein identifications were deter-
mined using the MassMatrix search engine (v 2.4.2) and
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the complete, reviewed Swiss-Prot entries from UniProt
(taxon:9606, 20,258 entries, July 2013) [62–65]. Search
parameters included a maximum of two trypsin missed
cleavages, molecular ion tolerance of ±20 ppm and a frag-
ment ion tolerance of ±0.8 Da. The false discovery rate
(FDR) was estimated using a target-decoy strategy. Final
protein identifications and spectral counts were harmo-
nized using an in-house python application [66]. Protein
identification from this harmonized protein list, were
retained based on an FDR threshold of 5 % where each
protein consisted of at least two unique peptide matches.
Size-exclusion chromatography of H1 complexes
Whole cell extracts of U2OS cells expressing 6 × His-
tagged H1 variants were applied to a Superose 6 10/300
GL column (GE Healthcare Life Sciences). The column
was washed with 1.5 column volumes of NP40 lysis
buffer. Proteins in each collected fraction were precipi-
tated with 20 % w/v TCA, then resolved and visualized
on western blots.
Immunofluorescence microscopy
U2OS cells seeded on cover slips were fixed in 4 % para-
formaldehyde for 20 min at room temperature and then
washed with PBS. The washed cells were permeabilized
with 0.5 % Triton X-100 in PBS for 15 min, then washed
with PBS three times, and blocked with blocking buffer
(1 % bovine serum albumin and 0.3 % Triton X-100 in
PBS) for 1 h. After blocking, the cells were incubated with
primary antibodies diluted in blocking buffer overnight
followed by three washes in PBST, and incubated with
secondary antibodies for 1 h. Then the cover slips with
cells were washed three times in PBS, and mounted onto
microscope slides with Vectashield mounting serum
containing DAPI (Vector Laboratories). The slides were
examined using Axioskop 40 microscope. Immunofluores-
cence pictures were taken with an Axiocam HRC camera
and processed in Zen 2 Pro software.
Quantification and analysis of immunofluorescence
Corrected total cell fluorescence (CTCF) was quantified
using ImageJ as previously described [67]. CTCF of anti-
Tpr and anti-His6 staining were standardized against
CTCF of DAPI staining. Regression analysis was carried
out using Microsoft Excel built-in statistical functions.
Quantitative real-time PCR analysis
RNAs were extracted from U2OS cells using Trizol reagent
(Thermo Fisher Scientific) following the manufacturer’s
instructions. The resulting RNAs were used to prepare
cDNAs using High Capacity cDNA Reverse Transcription
Kits (Applied Biosystems) following the manufacturer's
instruction. Levels of gene expression were measured
using TaqMan Gene Expression Assays (Applied Bio-
systems, Assay IDs as follows: H1.1 – Hs00271225_s1,
H1.2 – Hs00271185_s1, H1x – Hs00366688_s1, and
GAPDH – Hs02758991_g1), TagMan Universal PCR
Master Mix (Applied Biosystems) and the ABI 7300 se-
quence detector as previously described [68]. Expression
levels of histone H1 genes were normalized relative to
levels of GAPDH. Each experiment was completed on
three biological replicates where each biological replicate
was obtained in triplicate, and the mean of these values
was used for further analysis. Statistical analysis was
carried out using unpaired Student’s t-test: p ≤ 0.05
(*), p ≤ 0.01(**), and p ≤ 0.001(***).
Additional file
Additional file 1: Table S1. Protein identification report for H1 variant
associating proteins. The number of unique peptides determined by
mass spectrometry are given for each protein. Mock purification sample
from U2OS Tet/On cells without H1 vector insert was used as negative
control. Two technical replicates were analyzed for each H1 variant
sample. Four technical replicates were analyzed for the negative control.
(XLSX 67 kb)
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